246 related articles for article (PubMed ID: 27294605)
21. PAX8 expression in uterine malignant mesodermal mixed tumor (carcinosarcoma).
Holmes BJ; Gown AM; Vang R; Ronnett BM; Yemelyanova A
Int J Gynecol Pathol; 2014 Jul; 33(4):425-31. PubMed ID: 24901404
[TBL] [Abstract][Full Text] [Related]
22. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
[TBL] [Abstract][Full Text] [Related]
23. SATB2 as an Immunohistochemical Marker for Colorectal Adenocarcinoma: A Concise Review of Benefits and Pitfalls.
Berg KB; Schaeffer DF
Arch Pathol Lab Med; 2017 Oct; 141(10):1428-1433. PubMed ID: 28968158
[TBL] [Abstract][Full Text] [Related]
24. Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms.
Li Z; Roth R; Rock JB; Lehman A; Marsh WL; Suarez A; Frankel WL
Am J Clin Pathol; 2017 May; 147(5):484-491. PubMed ID: 28340228
[TBL] [Abstract][Full Text] [Related]
25. Malignant mixed Müllerian tumors of the uterus. An immunohistochemical study.
Auerbach HE; LiVolsi VA; Merino MJ
Int J Gynecol Pathol; 1988; 7(2):123-30. PubMed ID: 3294195
[TBL] [Abstract][Full Text] [Related]
26. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors.
Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
[TBL] [Abstract][Full Text] [Related]
27. SATB2 is not a reliable diagnostic marker for distinguishing between oral osteosarcoma and fibro-osseous lesions of the jaws.
Grad-Akrish S; Rachmiel A; Ben-Izhak O
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):572-581. PubMed ID: 33309262
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous Osteoblastic Osteosarcoma: Report of 2 New Cases Integrated With SATB2 Immunohistochemistry and Review of the Literature.
Falconieri G; Cataldi P; Kavalar R; Štitič V; Luzar B
Am J Dermatopathol; 2016 Nov; 38(11):824-831. PubMed ID: 27043339
[TBL] [Abstract][Full Text] [Related]
29. Colitis-associated colorectal adenocarcinomas are frequently associated with non-intestinal mucin profiles and loss of SATB2 expression.
Iwaya M; Ota H; Tateishi Y; Nakajima T; Riddell R; Conner JR
Mod Pathol; 2019 Jun; 32(6):884-892. PubMed ID: 30710095
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of matrix metalloprotease-7 in each component of uterine carcinosarcoma.
Tanimoto H; Shigemasa K; Sasaki M; Katayama H; Kusumi I; Parmley TH; O'Brien TJ; Ohama K
Oncol Rep; 2000; 7(6):1209-12. PubMed ID: 11032915
[TBL] [Abstract][Full Text] [Related]
31. Ampullary carcinosarcoma with osteosarcomatous, small cell neuroendocrine carcinoma and conventional adenocarcinoma components; First report.
Rao P; Sikora SS; Narayanaswamy S; Ghosal N; Kini D
Pathol Res Pract; 2016 Nov; 212(11):1071-1075. PubMed ID: 27640104
[TBL] [Abstract][Full Text] [Related]
32. The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic.
Perez Montiel D; Arispe Angulo K; Cantú-de León D; Bornstein Quevedo L; Chanona Vilchis J; Herrera Montalvo L
Ann Diagn Pathol; 2015 Aug; 19(4):249-52. PubMed ID: 26059401
[TBL] [Abstract][Full Text] [Related]
33. Heterologous carcinosarcoma of the fallopian tube. A case report.
O'Toole RV; Tuttle SE; Shah NT
J Reprod Med; 1982 Dec; 27(12):749-52. PubMed ID: 7161756
[TBL] [Abstract][Full Text] [Related]
34. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
[TBL] [Abstract][Full Text] [Related]
35. Uterine cervical carcinosarcoma with heterologous mesenchymal component: a case report and review of the literature.
Kadota K; Haba R; Ishikawa M; Kushida Y; Katsuki N; Hayashi T; Miyai Y; Bando K; Shiota A; Hata T
Arch Gynecol Obstet; 2009 Nov; 280(5):839-43. PubMed ID: 19263060
[TBL] [Abstract][Full Text] [Related]
36. Carcinosarcomas of the uterus and ovary: a clinicopathologic and immunohistochemical study of 11 cases.
Kondi-Pafiti A; Grapsa D; Hasiakos D; Gennatas K; Fotiou S
Eur J Gynaecol Oncol; 2009; 30(1):93-7. PubMed ID: 19317268
[TBL] [Abstract][Full Text] [Related]
37. Carcinosarcomas of the lung: a clinicopathologic study of 66 patients.
Koss MN; Hochholzer L; Frommelt RA
Am J Surg Pathol; 1999 Dec; 23(12):1514-26. PubMed ID: 10584705
[TBL] [Abstract][Full Text] [Related]
38. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
Chiesa-Vottero A
Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinomas can be Special AT-rich sequence-binding protein 2 positive: an important diagnostic pitfall.
Lee W; Li X; Chandan VS
Hum Pathol; 2020 Nov; 105():47-52. PubMed ID: 32946879
[TBL] [Abstract][Full Text] [Related]
40. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
